Your shopping cart is currently empty

Tubulin polymerization-IN-4 is an effective inhibitor of tubulin polymerization, and its IC₅₀ is 4.6 μM m. In HeLa cells, Tubulin polymerization-IN-4 can interfere with microtubule assembly and destroy the intracellular microtubule network, leading to cell cycle stagnation in G2/M phase, inducing cell apoptosis, and inhibiting cell clone formation and migration ability.

| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 25 mg | $1,520 | 10-14 weeks | 10-14 weeks | |
| 50 mg | $1,980 | 10-14 weeks | 10-14 weeks | |
| 100 mg | $2,500 | 10-14 weeks | 10-14 weeks |
| Description | Tubulin polymerization-IN-4 is an effective inhibitor of tubulin polymerization, and its IC₅₀ is 4.6 μM m. In HeLa cells, Tubulin polymerization-IN-4 can interfere with microtubule assembly and destroy the intracellular microtubule network, leading to cell cycle stagnation in G2/M phase, inducing cell apoptosis, and inhibiting cell clone formation and migration ability. |
| Targets&IC50 | HeLa cells:0.09 μM, SiHa cells:0.15 μM, HK-2 cells:188 μM, Tubulin:4.6 μM |
| In vitro | Tubulin polymerization-IN-4 (compound 9j) (0-1 μM; 48 hours) exhibits sub-micromolar inhibitory activities against HeLa, SiHa and MS751 [1]. Tubulin polymerization-IN-4 (3, 6 and 12.5 μM; 0-20 min) inhibits tubulin polymerization in a concentration-dependent manner with the inhibition percentages of 39%, 54%, and 77% at 3, 6 and 12.5 μM [1]. Tubulin polymerization-IN-4 (1-100 μM; 2 hours) inhibits the formation of EBI-β-tubulin adduct in a concentration-dependent manner [1]. Tubulin polymerization-IN-4 (0.2 μM; 1 and 2 hours) disrupts the HUVEC-formed vascular tube [1]. Tubulin polymerization-IN-4 (0.1-0.4 μM; 24 hours) increases cell distribution to the G2/M phase in a concentration-dependent manner [1]. Tubulin polymerization-IN-4 (0.1-0.4 μM; 24 hours) induces apoptosis of HeLa cells [1]. Tubulin polymerization-IN-4 (20, 50, 100 nM; 14 days) reduces new colony formation and suppresses HeLa cell growth for 14 days in a dose-dependent manner [1]. Tubulin polymerization-IN-4 (0.1, 0.2 and 0.4 μM; 24 hours) effectively inhibits the migration of HeLa cells in a concentration-dependent manner [1]. Tubulin polymerization-IN-4 (0-200 μM; 24 hours) exhibits good renal safety profile, with IC 50 of 188 ± 16 μM in HK-2 cells [1]. |
| In vivo | Tubulin polymerization-IN-4, administered intraperitoneally (IP) at doses ranging from 100 to 1000 mg/kg, exhibits very low toxicity, with its lethal dose 50 (LD50) exceeding 1000 mg/kg [1]. When given daily for 21 days at doses of 30 and 60 mg/kg, it effectively inhibits tumor growth, achieving tumor growth inhibition (TGI) rates of 35% and 58%, respectively, at these doses [1]. |
| Molecular Weight | 400.86 |
| Formula | C21H21ClN2O4 |
| Cas No. | 2835559-00-5 |
| Smiles | ClC1=CC(=CC=C1OCC)C2=CN=CN=C2C=3C=C(OC)C(OC)=C(OC)C3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.